Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Nurix Therapeutics, Inc. (NRIX)

27.26 +0.56 (+2.10%)
At close: October 28 at 4:00:00 PM EDT
27.35 +0.09 (+0.33%)
Pre-Market: 8:02:30 AM EDT
Trade NRIX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
11/30/2025
11/30/2024
11/30/2023
11/30/2022
Total Revenue
701,936
83,980
54,549
76,987
38,627
Operating Expense
412,279
369,646
267,576
232,050
222,494
Operating Income
289,657
-285,666
-213,027
-155,063
-183,867
Net Non Operating Interest Income Expense
18,555
21,969
19,728
11,115
3,507
Pretax Income
308,212
-263,697
-193,299
-143,948
-180,360
Tax Provision
13,335
760
270
0
0
Net Income Common Stockholders
294,877
-264,457
-193,569
-143,948
-180,360
Diluted NI Available to Com Stockholders
294,877
-264,457
-193,569
-143,948
-180,360
Basic EPS
2.53
-3.05
-2.88
-2.65
-3.71
Diluted EPS
2.43
-3.05
-2.88
-2.65
-3.71
Basic Average Shares
106,949.16
86,666.91
67,120.27
54,337.90
48,607.99
Diluted Average Shares
109,540.69
86,666.91
67,120.27
54,337.90
48,607.99
Total Operating Income as Reported
289,657
-285,666
-213,027
-155,063
-183,867
Total Expenses
412,279
369,646
267,576
232,050
222,494
Net Income from Continuing & Discontinued Operation
294,877
-264,457
-193,569
-143,948
-180,360
Normalized Income
294,877
-264,457
-193,569
-143,948
-180,360
Interest Income
18,555
21,969
19,728
11,115
3,507
Net Interest Income
18,555
21,969
19,728
11,115
3,507
EBIT
289,657
-285,666
-213,027
-155,063
-183,867
EBITDA
305,529
-266,810
-196,599
-141,409
-173,059
Reconciled Depreciation
15,872
18,856
16,428
13,654
10,808
Net Income from Continuing Operation Net Minority Interest
294,877
-264,457
-193,569
-143,948
-180,360
Normalized EBITDA
305,529
-266,810
-196,599
-141,409
-173,059
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
11/30/2022 - 7/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: